Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer

AIM: To identify suitable biomarkers of response to bevacizumab (BV) - it remains an open question. The measurement of serum vascular endothelial growth factor (VEGF) has been proposed as a predictive factor for this drug, even if literature data are contradictory. METHODS: We prospectively evaluate...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Gastroenterol
Главные авторы: Azzariti, Amalia, Porcelli, Letizia, Brunetti, Oronzo, Del Re, Marzia, Longo, Vito, Nardulli, Patrizia, Signorile, Michele, Xu, Jian-Ming, Calabrese, Angela, Quatrale, Anna Elisa, Maiello, Evaristo, Lorusso, Vito, Silvestris, Nicola
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2016
Предметы:
Prospective Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945987/
https://ncbi.nlm.nih.gov/pubmed/27468218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i27.6287
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы